Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma. [PDF]
Tur-Planells V +18 more
europepmc +1 more source
Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy. [PDF]
Morales-Molina A +5 more
europepmc +1 more source
Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma. [PDF]
Vile RG.
europepmc +1 more source
Oncolytic Virotherapy for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical and Research Strategies. [PDF]
Liu S, Liang R.
europepmc +1 more source
Resistance to oncolytic virotherapy: Multidimensional mechanisms and therapeutic breakthroughs (Review). [PDF]
Xu J, Xia Z, Wang S, Xia Q.
europepmc +1 more source
Multiparametric Detection of Effects of TILs and Oncolytic Virotherapy on Xenograft Mouse Model of Glioblastoma. [PDF]
Yusubalieva GM +15 more
europepmc +1 more source
Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer. [PDF]
Chen YC, Figueiredo ML.
europepmc +1 more source
Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment. [PDF]
Feng Y +11 more
europepmc +1 more source
Optimizing Oncolytic Virotherapy for Malignant Glioma: From Bench to Bedside. [PDF]
Jiang W, Tian Y, Gu H, Guan W.
europepmc +1 more source

